Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain-Reference-Cited by-同舟云学术

Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain

Published:2022-04-30 Issue:2 Volume:16 Page:63-71
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Román Ivorra José A¹,Llevat Noelia²,Montoro María

Affiliation:

1. Rheumatology Department, Hospital Universitari i Politècnic La Fe. Valencia. Facultad de Medicina y Ciencias de la Salud. Universidad Católica de Valencia, Spain.

2. Medical Department Pfizer, Madrid, Spain.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/16/2/16_2022.01028/_pdf

Reference58 articles.

1. 1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016; 388:2023-2038.

2. 2. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001; 27:269-281.

3. 3. Seoane-Mato D, Sánchez-Piedra C, Silva-Fernández L, et al. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology. Reumatol Clin. 2019; 15:90-96.

4. 4. Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017; 389:2338-2348.

5. 5. Chatzidionysiou K, Emamikia S, Nam J, Ramiro S, Smolen J, van der Heijde D, Dougados M, Bijlsma J, Burmester G, Scholte M, van Vollenhoven R, Landewé R. Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: A systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2017; 76:1102-1107.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in Italy;Current Medical Research and Opinion;2023-12-02

2. Tofacitinib in rheumatoid arthritis: Saudi real-world data;Annals of Rheumatology and Autoimmunity;2023

3. Estrogen antagonizes ASIC1a-induced chondrocyte mitochondrial stress in rheumatoid arthritis;Journal of Translational Medicine;2022-12-03